|
1
|
Rini B, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eggener SE, Yossepowitch O, Pettus JA,
Snyder ME, Motzer RJ and Russo P: Renal cell carcinoma recurrence
after nephrectomy for localized disease: Predicting survival from
time of recurrence. J Clin Oncol. 24:3101–3106. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miyake M, Kuwada M, Hori S, Morizawa Y,
Tatsumi Y, Anai S, Hosokawa Y, Hayashi Y, Tomioka A, Otani T, et
al: The best objective response of target lesions and the incidence
of treatment-related hypertension are associated with the survival
of patients with metastatic renal cell carcinoma treated with
sunitinib: A Japanese retrospective study. BMC Res Notes. 9:792016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bromwich EJ, McArdie PA, Canna K, McMillan
DC, McNicol AM, Brown M and Aitchison M: The relationship between
T-lymphocyte infiltration, stage, tumor grade and survival in
patients undergoing curative surgery for renal cell cancer. Br J
Cancer. 89:1906–1908. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Webster WS, Lohse CM, Thompson RH, Dong H,
Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML,
et al: Mononuclear cell infiltration in clear-cell renal cell
carcinoma independently predicts patient survival. Cancer.
107:46–53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Uzzo RG, Rayman P, Kolenko V, Clark PE,
Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, et
al: Mechanisms of apoptosis in T cells from patients with renal
cell carcinoma. Clin Cancer Res. 5:1219–1229. 1999.PubMed/NCBI
|
|
7
|
Rayman P, Wesa AK, Richmond AL, Das T,
Biswas K, Raval G, Storkus WJ, Tannenbaum C, Novick A, Bukowski R
and Finke J: Effect of renal cell carcinomas on the development of
type 1 T-cell responses. Clin Cancer Res. 10:6360S–6366S. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Condeelis J and Pollard JW: Macrophages:
Obligate partners for tumor cell migration, invasion, and
metastasis. Cell. 124:263–266. 2016. View Article : Google Scholar
|
|
9
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: Integrating immunity's roles in cancer suppression
and promotion. Science. 311:1565–1570. 2011. View Article : Google Scholar
|
|
10
|
Maxilloux AW and Young MR: Regulatory
T-cell trafficking: From thymic development to tumor-induced immune
suppression. Crit Rev Immunol. 30:435–447. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liotta F, Gacci M, Frosali F, Querci V,
Vittori G, Lapini A, Santarlasci V, Semi S, Cosmi L, Maggi L, et
al: Frequency of regulatory T cells in peripheral blood and in
tumour-infiltrating lymphocytes correlates with poor prognosis in
renal cell carcinoma. BJU Int. 107:1500–1506. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ye Z, Zheng Z, Li X, Zhu Y, Zhong Z, Peng
L and Wu Y: B7-H3 overexpression predicts poor survival of cancer
patients: A meta-analysis. Cell Physiol Biochem. 39:1568–1580.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fukuda T, Kamai T, Masuda A, Nukui A, Abe
H, Arai K and Yoshida K: Higher preoperative serum levels of PD-L1
and B7-H4 are associated with invasive and metastatic potential and
predictable for poor response to VEGF-targeted therapy and
unfavorable prognosis of renal cell carcinoma. Cancer Med.
5:1810–1820. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chapoval AI, Ni J, Lau JS, Wilcox RA,
Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K and Chen L:
B7-H3: A costimulatory molecule for T cell activation and IFN-gamma
production. Nat Immunol. 2:269–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Anthony LD, Richard ML and Miranda R:
Immunity: The immune response in infectious and inflammatory
disease. New Sci Press. 3872007.
|
|
16
|
Sobin LH, Gospodarowicz MK and Wittekind
CH: International union against cancer. UICC TNM classification of
malignant tumors. 7th. Wiley-Liss; pp. 255–257. 2009
|
|
17
|
Frank I, Blute ML, Cheville JC, Lohse CM,
Weaver AL and Zincke H: An outcome prediction model for patients
with clear cell renal cell carcinoma treated with radical
nephrectomy based on tumor stage, size, grade and necrosis: The
SSIGN score. J Urol. 168:2395–2400. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fuhman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thompson RH, Gillett MD, Cheville JC,
Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich
BC and Kwon ED: Costimulatory molecule B7-H1 in primary and
metastatic clear cell renal cell carcinoma. Cancer. 15:2084–2091.
2005. View Article : Google Scholar
|
|
20
|
Li L, Yang C, Zhao Z, Xu B, Zheng M, Zhang
C, Min Z, Guo J and Rong R: Skewed T-helper (Th)1/2- and Th17/T
regulatory-cell balances in patients with renal cell carcinoma. Mol
Med Rep. 11:947–953. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Petersen RP, Campa MJ, Sperlazza J, Conlon
D, Joshi MB, Harpole DH Jr and Patz EF Jr: Tumor infiltrating
Foxp3+ regulatory T-cells are associated with recurrence
in pathologic stage I NSCLC patients. Cancer. 107:2866–2872. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bates GJ, Fox SB, Han C, Leek RD, Garcia
JF, Hamis AL and Banham AH: Quantification of regulatory T cells
enables the identification of high-risk breast cancer patients and
those at risk of late relapse. J Clin Oncol. 24:5373–5380. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B,
Zhang Z, Yang H, Zhang H, Zhou C, et al: Increased regulatory T
cells correlate with CD8 T-cell impairment and poor survival in
hepatocellular carcinoma patients. Gastroenterology. 132:2328–2339.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hiraoka N, Onozato K, Kosuge T and
Hirohashi S: Prelavence of Foxp3+ regulatory cells
increases during the progression of pancreatic ductal
adenocarcinoma and its premalignant lesions. Clin Cancer Res.
12:5423–5434. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Curiel TJ, Coukos G, Zou L, Alvarez X,
Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L,
Burow M, et al: Specific recruitment of regulatory T cells in
ovarian carcinoma fosters immune privilege and predicts reduced
survival. Nat Med. 10:942–949. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Polimeno M, Napolitano M, Costantini S,
Portella L, Esposito A, Capone F, Guerriero E, Trotta A, Zanotta S,
Pucci L, et al: Regulatory T cells, interleukin (IL)-6, IL-8,
vascular endothelial growth factor (VEGF), CXCL10, CXCL11,
epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as
surrogate markers of host immunity in patients with renal cell
carcinoma. BJU Int. 112:686–696. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun Y, Wang Y, Zhao J, Gu M, Giscombe R,
Lefvert AK and Wang X: B7-H3 and B7-H4 expression in non-small-cell
lung cancer. Lung Cancer. 53:143–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M,
Tan Y, Wang HT, Lu BF and Zhang XG: Clinical significance and
regulation of the costimulatory molecule B7-H3 in human colorectal
carcinoma. Cancer Immunol Immunother. 59:1163–1171. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Crispen PL, Sheinin Y, Roth TJ, Lohse CM,
Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich
BC, et al: Tumor cell and tumor vasculature expression of B7-H3
predict survival in clear cell renal cell carcinoma. Clin Cancer
Res. 14:5150–5157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
von Boehmer H: Mechanism of suppression by
suppressor T cells. Nat Immunol. 6:338–344. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou X, Mao Y, Zhu J, Meng F, Chen Q, Tao
L, Li R, Fu F, Liu C, Hu Y, et al: TGF-β1 promotes colorectal
cancer immune escape by elevating B7-H3 and B7-H4 via the
miR-155/miR-143 axis. Oncotarget. 7:67196–67211. 2016.PubMed/NCBI
|
